Frazer, Monica
Swift, Caroline
Sargent, Andrew
Leszko, Michael
Buysman, Erin
Gronroos, Noelle N.
Alvarez, Sara
Dunn, Tyler J.
Noone, Josh
Gamble, Cory L.
Funding for this research was provided by:
Novo Nordisk (Novo Nordisk)
Article History
Received: 21 August 2023
Accepted: 31 October 2023
First Online: 27 November 2023
Declarations
:
: CS, SA, TD, JN and CG are employees of Novo Nordisk. MF was an employee of Optum at the time the study was conducted and is currently employed at QualityMetric. AS, ML, NNG, and EB are employees of Optum.
: Institutional review board approval or waiver of approval was not required for this study because the study data were secondary and de-identified in accordance with the United States Department of Health and Human Services Privacy Rule’s requirements for de-identification codified at 45 C.F.R. § 164.514(b).
: Throughout the process, patient privacy was preserved, and researchers complied strictly with all applicable Health Insurance Portability and Accountability Act data management rules and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.